- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
- S-4 Registration of securities issued in business combination transactions
- 10.34 Exhibit 10.34
- 10.35 Exhibit 10.35
- 10.36 Exhibit 10.36
- 10.37 Exhibit 10.37
- 10.38 Exhibit 10.38
- 10.39 Exhibit 10.39
- 10.40 Exhibir 10.40
- 10.41 Exhibit 10.41
- 10.42 Exhibit 10.42
- 10.43 Exhibit 10.43
- 10.44 Exhibit 10.44
- 10.45 Exhibit 10.45
- 21.1 Exhibit 21.1
- 23.3 Consent of Independent Registered Public Accounting Firm
- 23.4 Exhibit 23.4
- 99.1 Exhibit 99.1
- 99.2 Exhibit 99.2
- 99.3 Exhibit 99.3
- 99.4 Exhibit 99.4
- 99.7 Exhibit 99.7
- 99.8 Exhibit 99.8
- 99.9 Exhibit 99.9
- 99.10 Exhibit 99.10
- 99.11 Exhibit 99.11
- 14 Apr 21 EFFECT Notice of effectiveness
- 13 Apr 21 424B3 Prospectus supplement
- 9 Apr 21 S-4/A Registration of securities issued in business combination transactions (amended)
-
30 Mar 21 S-4 Registration of securities issued in business combination transactions
Exhibit 99.4
CONSENT OF MAXIM GROUP LLC
March 29, 2021
We hereby consent to (i) the inclusion of our opinion letter, dated January 18, 2021, to the Board of Directors of ReShape Lifesciences Inc. (“ReShape”) as Annex B to the joint proxy statement/prospectus which forms a part of the Registration Statement on Form S-4 of Obalon Therapeutics, Inc. (“Obalon”) filed with the Securities and Exchange Commission on March 22, 2021 relating to the proposed merger of ReShape and Optimus Merger Sub, Inc., a wholly owned subsidiary of Obalon and (ii) the references to such opinion in such joint proxy statement/prospectus. In giving such consent, we do not admit that we come within the category of persons whose consent is required under Section 7 of the Securities Act of 1933, as amended, or the rules and regulations of the Securities and Exchange Commission thereunder, nor do we hereby admit that we are experts with respect to any part of such Registration Statement within the meaning of the term “experts” as used in the Securities Act of 1933, as amended, or the rules and regulations of the Securities and Exchange Commission thereunder.
Very truly yours, | |
/s/ Maxim Group LLC | |
MAXIM GROUP LLC |